We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RAPT market cap is 601.25M. The company's latest EPS is USD -2.4374 and P/E is -7.16.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.68M | -24.43M | -31.56M | -28.36M | -33.92M |
| Net Income | -21.24M | -22.95M | -29.27M | -25.28M | -31.37M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 5.04M | 3.81M | 1.53M |
| Operating Income | -36.95M | -43.63M | -53.21M | -69.21M | -85.8M |
| Net Income | -36.15M | -43M | -52.89M | -69.2M | -83.84M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 209.49M | 266.21M | 248.33M | 220.76M | 199.72M |
| Total Liabilities | 20.18M | 21.04M | 27.86M | 21.08M | 26.92M |
| Total Equity | 189.31M | 245.17M | 220.47M | 199.68M | 172.8M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 69.61M | 84.6M | 118.97M | 198.64M | 266.21M |
| Total Liabilities | 5.61M | 11.48M | 14.79M | 12.26M | 21.04M |
| Total Equity | -97.11M | 73.12M | 104.18M | 186.38M | 245.17M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -47.92M | -70.77M | -18.6M | -47.41M | -69.29M |
| Investing | -4.22M | -45.49M | 25.31M | 57.75M | 83.49M |
| Financing | 55.82M | 131.18M | 116k | 883k | 989k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -32.95M | -35.47M | -40.49M | -61.03M | -70.77M |
| Investing | -3.5M | -843k | -87.44M | -81.35M | -45.49M |
| Financing | 52.73M | 49.9M | 75.46M | 141.48M | 131.18M |
| Market Cap | 601.25M |
| Price to Earnings Ratio | -7.16 |
| Price to Sales Ratio | 393.24 |
| Price to Cash Ratio | 15.42 |
| Price to Book Ratio | 2.45 |
| Dividend Yield | - |
| Shares Outstanding | 34.4M |
| Average Volume (1 week) | 445.51k |
| Average Volume (1 Month) | 370.68k |
| 52 Week Change | 0.81% |
| 52 Week High | 31.4499 |
| 52 Week Low | 10.47 |
| Spread (Intraday) | 2.16 (11.63%) |
| Company Name | RAPT Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.rapt.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
